Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1

Detalles Bibliográficos
Autores principales: Smith, Kellie N., Llosa, Nicolas J., Cottrell, Tricia R., Siegel, Nicholas, Fan, Hongni, Suri, Prerna, Chan, Hok Yee, Guo, Haidan, Oke, Teniola, Awan, Anas H., Verde, Franco, Danilova, Ludmila, Anagnostou, Valsamo, Tam, Ada J., Luber, Brandon S., Bartlett, Bjarne R., Aulakh, Laveet K., Sidhom, John-William, Zhu, Qingfeng, Sears, Cynthia L., Cope, Leslie, Sharfman, William H., Thompson, Elizabeth D., Riemer, Joanne, Marrone, Kristen A., Naidoo, Jarushka, Velculescu, Victor E., Forde, Patrick M., Vogelstein, Bert, Kinzler, Kenneth W., Papadopoulos, Nickolas, Durham, Jennifer N., Wang, Hao, Le, Dung T., Justesen, Sune, Taube, Janis M., Diaz Jr, Luis A., Brahmer, Julie R., Pardoll, Drew M., Anders, Robert A., Housseau, Franck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402146/
https://www.ncbi.nlm.nih.gov/pubmed/30841906
http://dx.doi.org/10.1186/s40425-019-0547-7

Ejemplares similares

Ejemplares similares